Empagliflozin is used to:
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Avoid using Emjard 10mg Tablet in the following situations:
Emjard 10mg Tablet may cause fainting, dizziness, or lightheadedness. If you experience these symptoms, sit down immediately.
Consumption of this medication with alcohol may hinder blood glucose levels for diabetes patients.
Emjard 10mg Tablet is not recommended for use during pregnancy.
Emjard 10mg Tablet is not recommended for use during breastfeeding. Please consult your doctor.
Emjard 10mg Tablet should not affect your ability to drive or operate machinery/tools.
Emjard 10mg Tablet should be taken with caution in patients with severe kidney disease and serious infection of the kidney. Consult your doctor before taking it.
Emjard 10mg Tablet should be used with caution in patients with severe liver disease. Consult your doctor before taking it.
Emjard 10mg Tablet is a medication that works by inhibiting a protein called SGLT2 in the kidneys. This action leads to the removal of glucose (blood sugar) from the bloodstream and its excretion in the urine. By reducing the concentration of sugar in the blood, Emjard 10mg Tablet helps manage and control blood sugar levels in individuals with type 2 diabetes.
Additionally, Emjard 10mg Tablet has been shown to have cardiovascular benefits. It can help protect the heart and reduce the risk of heart-related complications in people with diabetes.
Common side effects include urinary tract infections, female genital mycotic infections, dehydration, hypotension, weakness, dizziness, and increased thirst.
Patients with a history of serious hypersensitivity reactions to Empagliflozin or any of its ingredients, severe renal impairment, end-stage renal disease, or dialysis should not take Empagliflozin.
Store below 30°C, protected from light and moisture, and keep out of reach of children.